Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Genetisch risico hemochromatose geassocieerd met ijzerstapeling en bewegingsstoornissen
aug 2022 | Bewegingsstoornissen